Back to Treatments

Treatment

MAO-B Inhibitors (e.g., Rasagiline, Selegiline)

1
Conditions
70
Trials
15K
Participants
70%
Average Safety

Condition Evidence

Parkinson's disease

70 trials · 15K participants

70% effectiveness · 70% safety
MAO-B Inhibitors (e.g., Rasagiline, Selegiline) | DFDA